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Abstract 
The pathology of multiple sclerosis (MS) is typified by focal demyelinated areas of the brain 
and spinal cord, which results in axonal degeneration and atrophy. Although the field has 
made much progress in developing immunomodulatory therapies to reduce the occurrence 
of these focal lesions, there is a conspicuous lack of licensed effective therapies to reduce 
axonal degeneration or promote repair. Remyelination, carried out by oligodendrocytes, does 
occur in MS, and is protective against axonal degeneration. Unfortunately, remyelination is 
not very efficient, and ultimately fails and so there is a research focus to generate new 
therapeutics to enhance remyelination leading to neuroprotection. 
To develop these therapies, we need preclinical models that well reflect remyelination in MS. 
We have previously characterized an ex vivo model that uses lysophosphatidylcholine (LPC) 
to cause acute and global demyelination of tissue slices, followed by spontaneous 
remyelination, which has been widely used as a surrogate for in vivo rodent models of 
 
 
2 
 
demyelination. However, this ex vivo model lacks the focal demyelinated lesions seen in MS, 
surrounded by normal tissue from which the repairing oligodendrocytes are derived. 
Therefore, to improve the model, we have developed and characterized small macroporous 
cryogel scaffolds for controlled/regional delivery of LPC with diameters of either 0.5, 1 or 2 
mm. Placement of LPC loaded scaffolds adjacent to ex vivo cultured mouse brain and spinal 
cord slices induced focal areas of demyelination in proximity to the scaffold. To the best of 
our knowledge, this is the first such report of spatial mimicry of the in vivo condition in ex vivo 
tissue culture. This will allow not only the investigation into focal lesions, but also provides a 
better platform technology with which to test remyelination-promoting therapeutics.  
 
1 Introduction 
Multiple sclerosis (MS) is an auto-immune and neurodegenerative disease causing focal areas 
of demyelination in the brain and spinal cord. It is the most common cause of non-traumatic 
neurological disability in young adults and affects around two million people worldwide [1, 
2]. MS is a purely human disease, so, in order to study it, researchers have developed several 
models in other species. These various models capture different aspects of the disease, but 
no single model fully recapitulates the human condition (reviewed in [3]). With the help of 
the immune-driven models, where activated T cells drive demyelination, the research 
community has developed very successful immunomodulatory drugs which reduce the 
number of new MS lesions and symptomatic relapses in relapsing-remitting MS (reviewed in 
[4]). However, we are still far from a successful neuroprotective therapy which could slow, 
prevent or reverse accumulation of disability in progressive MS by reducing 
neurodegeneration. One strategy for neuroprotection is to encourage remyelination – where 
oligodendrocytes replace damaged myelin sheaths which restores saltatory nerve impulse 
conduction and provides metabolic support for the underlying axon [5]. Remyelination occurs 
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in MS but is inefficient and always ultimately fails [6, 7]. To test pro-remyelination 
compounds, different in vivo models have been developed to examine the remyelination 
response. In vivo toxin models aim to destroy white matter myelin in a focal way using 
stereotactic injections of lysolecithin (lysophosphatidylcholine, LPC) or both grey and white 
matter in a global manner using ingested cuprizone. The advantage of using LPC is that the 
location of the damage is known, demyelination and remyelination are separated and there 
is a well-characterized repair tempo [8, 9]. However, this is an in vivo model which is not 
suitable for high or even moderate throughput screening for pro-remyelinating therapeutics. 
For this reason, we previously characterized an ex vivo model of demyelination and 
remyelination using LPC applied to slices of brain and spinal cord grown in culture [10]. This 
technique, first introduced by Birgbauer et al., [11] involves the culture of 300 µm thick 
postnatal rodent brain slices and then demyelination of the whole slice, using LPC added to 
the culture medium. This has been very useful in screening compounds with relative ease, 
allowing selection of suitable compounds for further analysis in vivo. This model has been 
adopted throughout the myelin research community to test pro-remyelinating compounds 
[12-14], some of which have now entered clinical trials e.g. ClinicalTrials.gov Identifier: 
NCT03222973, EudraCT Number: 2014-003145-99.  This method has the advantage of easy 
manipulation as drugs can be simply added to the culture medium.  
Pro-remyelinating drugs may either increase the recruitment of the oligodendrocyte 
precursor cell (OPC) to a focal demyelinated MS lesion or to enhance the speed of OPC 
differentiation within this focal lesion into a remyelinating oligodendrocyte [5]. These appear 
to be critical steps in enhancing remyelination, as around 60% of post mortem MS 
demyelinated lesions contain OPCs apparently stalled in differentiation and in the remaining 
30%, there is a low number of OPCs, suggesting a lack of recruitment from surrounding normal 
appearing “healthy” tissue [15]. A focal area of demyelination leads to locally-generated 
chemotactic cues forming a gradient of signals for cells to respond to, which is absent after 
global demyelination [8, 16, 17]. Our current system of global demyelination does not reflect 
the focal lesions of demyelination, surrounded by normal appearing white and grey matter 
found in MS, so we cannot test drugs enhancing recruitment, as there is no normal tissue 
from which to recruit from. To rectify this problem, and provide a better preclinical ex vivo 
model, we set out to generate and characterize a model of focal demyelination in rodent brain 
 
 
4 
 
and spinal cord slice cultures, using biomaterial scaffolds to deliver LPC to only one area of 
the tissue slice rather than to the whole tissue. 
One such group of biomaterial scaffolds that has been extensively investigated as drug 
delivery systems in tissue engineering and regenerative medicine are hydrogels based on 
poly(ethylene glycol) [18-22]. They are chemically cross-linked and water-insoluble three-
dimensional hydrophilic polymer networks. They are generally non-toxic/non-immunogenic, 
and have high small molecule permeability and mechanical properties that can be tailored to 
that of tissues. Hydrogels, however, have significant drawbacks for use in ex-vivo cultures [23, 
24] as they dehydrate quickly and lose their shape when they are not permanently covered 
or exposed to aqueous conditions. Additionally, when they are transferred into their swollen 
state, hydrogels exhibit low mechanical stability and thus can become difficult to 
move/handle. Consequently, controlling the loading and delivery of drugs from such gels is 
challenging. An alternative biomaterial, also based on poly(ethylene glycol) starting materials, 
involves the chemical crosslinking of the monomeric precursor solution under freezing 
conditions. The resulting materials, termed cryogelated hydrogels (or cryogels) typically 
exhibit macroporous structures that are highly interconnected, with mechanically strong 
struts and stiff pore walls [25-27]. Cryogels exhibit high mechanical deformability without 
being destroyed and have remarkable shape memory with additional reversible and fast-
swelling properties [28-30]. These beneficial features motivated us to investigate their use as 
an easy-to-handle scaffold for delivery of LPC focally to brain slice cultures.  
 
2 Materials and Methods 
2.1 Materials 
All chemicals and consumables were used as received unless otherwise stated. Poly(ethylene 
glycol) diacrylate (PEGDA) (Mn = 700 g/mol), 2-hydroxy-2-methylpropiophenone (HMPP), 
phosphate buffered saline (PBS), bovine serum albumin (BSA), absolute ethanol (EtOH) and 
Corning Costar TC-treated multiple size 6 well plates were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). Two types of LPC were used for these studies: the “standard” LPC used for 
the ex vivo studies (Sigma, L1381) and the fluorescent analogue 1-(dipyrrometheneboron 
difluoride)undecanoyl-2-hydroxy-sn-glycero-3-phosphocholine (TopFluor®Lyso PC) (Sigma, 
810284P). ATTO 647-labeled maleimide was obtained from ATTO-TEC (Siegen, Germany). 
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Hydrophilic PTFE cell culture inserts with a diameter of 30 mm and a pore size of 0.4 µm were 
purchased from Merck Millipore (Darmstadt, Germany). Polystyrene templates with 0.5 mm, 
1mm and 2 mm diameter cavities were self-made. All water used was highly purified and 
deionized using a Milli-Q® ('ultrapure' water of "Type 1") integral water purification system 
from Merck Millipore (Darmstadt, Germany).  
2.2 Synthesis of macroporous cylindrical cryogels  
The cylindrical cryogels were synthesized in polystyrene templates via photochemical 
crosslinking. The templates were created by drilling 0.5 mm, 1 mm or 2 mm holes through a 
polystyrene sheet (Evergreen Scale Models, USA) of different thickness (0.5 mm, 0.7 mm or 
1.5 mm respectively, as reported by the manufacturer). One side of the template was covered 
by Scotch MagicTM Tape (3M, Maplewood, Minnesota, U.S.A.) to cover the hole, thus creating 
a cavity in which the cryogels are be synthesized. An aqueous precursor solution was freshly 
prepared prior to use, containing 70 mg/mL PEGDA monomer and 10 mg/mL HMPP as a 
photoinitiator. 0.13 µL, 0.78 µL or 5.02 µL of this solution were added to the respective 
cavities. The filled templates were then placed in the freezer for 30 minutes at a processing 
temperature of -20°C. Then, each template was exposed to UV light (8 W UV hand lamp, 
wavelength 254 nm, Benda, Wiesloch, Germany) for 3 minutes whilst still at -20°C. The 
resulting cylindrical cryogels were removed from their template and washed two times with 
absolute ethanol and two times with Milli-Q in order to remove unbound monomers or 
photoinitiator. Finally, the cryogels were left to dry for 5 hours in a vacuum at room 
temperature. 
2.3 Template characterization by multi-pinhole confocal microscopy  
The dimensions and the topography of the empty and cryogel filled polystyrene templates 
were analyzed via multi-pinhole confocal microscopy utilizing a μsurf explorer (NanoFocus 
AG, Germany) equipped with a 10x objective (Olympus, Germany). 2D and 3D height maps 
were generated, and profile sections were recorded using μSoft analysis software (NanoFocus 
AG). 
2.4 Cryogel characterization by Raman spectroscopy  
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The Raman spectra of the cylindrical cryogels were recorded and baseline corrected with the 
Raman Imaging System alpha300R (WITEC, Ulm, Germany) in the 600–1900 cm−1 frequency 
range (excitation wavelength: 785 nm, laser power: 130 mW, objective: 20x (Zeiss), 
integration time: 0.5 s, accumulation per spectrum: 200). The spectra of the PEGDA monomer 
solution and the precursor solution, which contained the monomer and photoinitiator, were 
used as references. 
2.5 Cryogel characterization by Fourier transform infrared spectroscopy (FTIR) 
Infrared spectra of the cylindrical cryogels were obtained and baseline corrected using a 
Bruker Vertex 80v (Billerica, USA) equipped with a Golden GateTM single reflection diamond 
attenuated total reflectance probe (ATR) system from SPECAC (Orpington, U.K.) in the 600–
4000 cm−1 frequency range (MCT-detector, resolution = 4 cm-1, 100 scans per measurement). 
The spectrum of the PEGDA monomer was used as a reference. 
2.6 Scanning electron microscopy analysis of the cryogels (SEM) 
Surface and pore morphological features of the cylindrical cryogels were visualized by means 
of a XL30 ESEM-FEG microscope (Philips, Netherlands) in high vacuum mode using an 
accelerating voltage of 7.5 kV. Samples were fixed to aluminum stubs with double-sided 
adhesive carbon conductive tape and subsequently sputter-coated with gold using a SCD 050 
sputter coater (BAL-TEC, Germany) for 40 s at 40 mA. 
2.7 Swelling measurements 
Swelling studies were carried out in PBS (pH 7.4) containing 1% (w/v) BSA at room 
temperature (23 °C). Before swelling, the dry cryogels were scanned with the fluorescent 
image analyzer FLA-5000 (Fujifilm, Japan) and the average diameter was measured for every 
cylinder by a three-point determination method using the Multi Gauge analysis software 
(Fujifilm, Japan). Afterwards, the cylindrical cryogels were immersed in 2 mL of the buffer 
containing BSA for 24 hours at room temperature until the equilibrium was reached. The final 
diameter of the swollen cryogels was measured immediately after the removal of excess 
buffer from the cryogel surface. At least six independent experiments were carried out (n = 
6). The volume swelling degree Qv for the cryogels was obtained from the diameter of the 
swollen d and the dry cryogel d0 via equation (1) 
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                                                                                                                                 (1) 
2.8 Pore size analysis via confocal laser scanning microscopy (CLSM) 
CLSM was used to visualize and measure the pore size of the cylindrical cryogels in the 
hydrated state (in PBS). Therefore, the cryogels were labeled by adding 0.1 mg/mL of ATTO 
647-labeled maleimide to the precursor solution, followed by a subsequent photochemical 
crosslinking analogously to the cryogel synthesis. CLSM was performed with a Dragonfly 
(Andor Technology, U.K.) mounted on a Nikon Ti-E inverted microscope with a 637 nm laser 
and diode and images were taken with either a 10x magnification objective (CFI Plan Apo 
Lambda, Nikon), or a 20x magnification objective (CFI Plan Apo Lambda, Nikon). Pore sizes 
were analyzed from 15 images taken from 8 different z-planes with a distance of 2.3 µm 
between each plane, measuring a total of 300 pores in both x- and y-directions using ImageJ 
software (NIH). The surface area of the pores was analyzed using algorithm functions of the 
ImageJ software. The pore volume analysis was performed using Imaris software v. 9.30 
(Bitplane AG, Zurich, Switzerland). The software's built-in wizard was used to perform a 
surface reconstruction function, which enabled calculation of the volume of interest from a 
newly generated surface object. The porosity was calculated from the ratio of pore volume 
to the total cryogel cylinder volume. 
2.9 Compression rheology  
Uniaxial compression tests were performed on 9 mm diameter and 3 mm height PBS swollen 
cylindrical cryogels at room temperature under atmospheric conditions by using an ARES G2 
Rheometer (TA Instruments, New Castle, DE, U.S.A.). Samples were compressed between two 
parallel plates (stainless steel, diameter 8 mm) with a constant linear compression rate of 1 
mm/min. The compressive modulus (E) of the cryogels was calculated via equation (2) using 
the uniaxial stress (σ) and strain (ϵ) parameters from the linear region of the compression 
curves at low strain regions (0−5% up to 25%) that were obtained through ten independently 
performed experiments. 
                                                                                                                                             (2) 
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2.10 Lysophosphatidylcholine (LPC) loading and release analysis 
The LPC loading and release analysis was performed by using TopFluor®Lyso PC, a 
fluorescently labeled LPC analogue. The LPC was first dissolved in sterile phosphate buffered 
saline (PBS) at a concentration of 10 mg/mL (termed the loading stock solution) and the 
cylindrical cryogels (n = 4 for each diameter type) were subsequently incubated in 100 µL of 
this solution for 5 minutes at 37°C. After the incubation time, the LPC soaked cryogels were 
carefully blotted with a lint-free tissue in order to remove the excess and thus unbound LPC. 
Afterwards, the cryogels were immediately placed individually on 30 mm diameter PTFE cell 
culture inserts (0.4 µm pore size) in six-well plates with 1 mL of fresh brain slice medium 
underneath. This is to mimic the situation where these are applied to cultured tissue slices. 
The amount of LPC loaded was determined by measuring the volume of the remaining loading 
stock solution and subtracting this from the initial volume of 100 µL.  
To determine whether additional LPC was depleted from the loading solution by the cryogel 
(i.e. determine if electrostatic loading was taking place) the fluorescence intensity of the 
remaining incubation volume was measured in comparison to an equal volume of the LPC 
loading stock solution that was not used for incubation. 
To measure how much LPC was released from the cryogel to the medium under the insert, 
200 µL of the undernatant was removed and replaced with fresh slice medium at each time 
point (incubated at 37 °C). The collected volumes were stored at – 80 °C until analyzed 
fluorometrically using a microplate reader Spark® (Tecan Trading AG, Switzerland, excitation 
wavelength λexc = 477 nm and emission wavelength λem = 527 nm) in comparison to a standard 
curve. The amount of LPC removed for each time point was factored into the calculation of 
total LPC release.  
2.11 Slice cultures 
All animal experiments were carried out in line with UK Home Office guidelines, under project 
license 60/4524 (A.W.). LPC used for these studies was not fluorescently labelled (Sigma, 
L1381). 
Spinal Cord Slices 
P0-P2 C57BL6/N mouse pups were decapitated and cervical spinal cord (about 3mm in length) 
was collected in ice cold L-15 (Life Technologies, 11415049). Meninges and blood vessels were 
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removed using fine forceps and the spinal cord was cut into 300 µm longitudinal slices, using 
a tissue chopper (Mcllwain). Spinal cord slices were collected using a bent spatula into 
warmed slice medium consisting of 50% MEM (Invitrogen, 32360-026) with 25% Earle’s 
Balanced Salt Solution (Invitrogen, 24010-043), 25% heat-inactivated horse serum 
(Invitrogen, 26050-088), 1% glutamax supplement (Invitrogen, 35050-038), 1% penicillin–
streptomycin, 0.5% Fungizone (Invitrogen, 15290-018) and 6.5 mg/ml glucose (Sigma G8769). 
Slices were separated using blunt scalpels or needles. Separated slices were placed onto 
Millicell cell culture inserts which are placed in a six-well plate and have 1 mL slice culture 
medium underneath the insert. These air-liquid interface slice cultures were cultured for 15-
20 days with medium changes every 2 days at 37 °C and 7.5% CO2. For focal demyelination, 
0.5 mm cryogels were soaked in 10 mg/mL LPC in PBS for 5 minutes. These were then placed 
adjacent to spinal cord slices (using forceps) but not in direct contact with slice (photographs 
were taken to help locate the site of lesion when processed for immune labelling). Cryogels 
were removed after 16 hrs (as optimized previously [10]) and the medium changed. Slices 
were fixed at desired time points for immunostaining. The day of the cryogel placement was 
considered as day 0. Day 3 was considered the time-point for maximal demyelination and day 
14 the time-point for remyelination when the slices were processed for immunofluorescent 
labelling. For the control group, slice saline-soaked cryogels were placed adjacent to the 
spinal cord slices on Day 0 and removed 16hrs later. 
Cortical Slices 
P2–P3 C57BL6/N mouse pups were decapitated and their brains were dissected in cold 
Hibernate-A medium (Thermo Fisher A12475-01) on ice. Subsequently the brains were 
mounted on a vibratome (Leica) and 300 μm coronal cortical slices were collected in ice cold 
Hibernate-A medium. The slices were immediately transferred onto Millicell cell culture 
inserts (30 mm, hydrophilic PTFE, 0.4 µm, Merck-Millipore, PICM0RG50) using a bent spatula 
and in medium (composition as described in spinal cord slices). The slices were kept in culture 
for 16 days at 37 °C and 7.5% CO2. The medium was changed every other day. Focal 
demyelination of the cortex was obtained by soaking 2.0 mm cryogels in 10 mg/ml of LPC and 
by placing them adjacent to the cortex for 16 hrs (as optimized previously [10]). The bigger 
cryogel size was found to be more effective for the larger cortical slices. For the control group, 
saline-soaked cryogels were placed adjacent to the cortical slices for 16 hours and then 
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removed. After this period, the cryogels were removed and the medium was replaced. The 
day of the LPC-cryogel placement was considered as day 0. Day 5 was considered the time-
point for maximal demyelination and day 14 the time-point for remyelination when the slices 
were processed for immunofluorescent labelling.  
 
Multiple tissue slices can be placed on each Millicell insert in a six well plate. As cortical slices 
are rather large, we suggest placing no more than 4 on an insert. Spinal cord slices are smaller 
and so 5 can be placed on an insert. Use of more than this number per insert risks that LPC 
loaded into the multiple cryogels releases too much LPC into the underlying culture medium 
producing a global effect. 
 
2.12 Slice culture immunofluorescence 
Cortical and spinal cord slices were washed once with PBS before they were fixed with 4% 
paraformaldehyde (PFA) in PBS for 1 hr at RT. The slices were subsequently rinsed in PBS and 
blocked in 3% heat-inactivated horse serum (Invitrogen, 26050-088), 2% BSA (Sigma, A7906), 
and 0.5% Triton X-100 in PBS for 2 hrs at RT. Following blocking, the slices were incubated for 
48 hrs with primary antibodies at 4 °C. The slices were then washed 3 times with blocking 
solution and incubated with the appropriate secondary antibodies overnight at 4 °C. Finally, 
the slices were washed in PBS, counterstained with Hoechst 33342 solution (Thermo Fisher 
Scientific, 62249) and mounted on a glass microscopic slide using Mowiol mounting medium 
(Merck Millipore, 475904). The primary antibodies used were as follows: against myelin basic 
protein (rat monoclonal anti-MBP, MCA409S, BioRad, 1:300), Neurofilament-H (chicken 
polyclonal anti-NF-H, Biolegend, 822601. 1:10.000), IBA-1 (rabbit polyclonal, Wako chemicals, 
019-19741 1:500). Secondary antibodies were all purchased from Life Technologies (Alexa, 
1:1000). Images were obtained using confocal laser scanning microscopy (Leica microsystems, 
TCS SP8) and processed using Fiji image processing package (https://imagej.net/Fiji). 
2.13 Statistical analysis 
All graphs shown means plus error bars that represent either +/- standard deviation or 
standard error of means as stated in the figure legend. Differences between groups were 
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analyzed using a one-way ANOVA with Tukey post-hoc test. Data were considered significant 
if  *P<0.05, ** P<0.01,  *** P<0.001 or ****P<0.0001. Numbers of animals used for each 
experiment is stated in each figure legend. 
3 Results 
3.1 Successful formation of cylindrical and macroporous PEGDA cryogels 
PEGDA based cylindrical cryogel scaffolds were successfully synthesized by free radical 
photopolymerisation at a subzero processing temperature (-20 °C) in polystyrene template 
sheet cavities, exhibiting interconnecting macropores within their network structure (Figure 
1).  
The resulting dimensions of the three variations of the cryogel scaffolds were 0.49 x 0.68 mm 
(diameter x height), 0.88 x 0.92 mm and 1.80 x 1.60 mm as determined from the profile 
measurements, which were obtained by means of multi-pinhole confocal microscopy analysis 
(Figure 2, Supporting Information Figures S1, S2 and Table S1). However, these are termed 
by their intended diameter henceforward as 0.5 mm, 1 mm and 2 mm respectively. In 
addition, the confocal multi-pinhole observations also showed the porous cryogel structure 
for all three different cylinder sizes, which completely filled the cavities without the 
appearance of a meniscus like shape or over fillings (Figure 2A-D, Figures S1 A-D and Figure 
S2A-D).  
3.2 Cylindrical PEGDA cryogels exhibit a sponge-like morphology   
The morphological analysis was carried out using SEM and confocal laser scanning 
fluorescence microscopy (CLSM). From SEM observations, the PEGDA cryogels exhibited a 
compact structure of interconnected macropores with a heterogeneous sponge-like 
morphology (Figure 3A-C and Supporting Information Figure S3A-F). All scaffolds also 
appeared to have rather randomly shaped but evenly distributed lamellar-like pores within 
or on top of the sponge-like structure with no overall defects (Figure S3A-F). Whilst SEM 
analysis was used to reveal the cryogel structure in the dehydrated state, CLSM was 
performed to study the pore structure under hydrated conditions (application relevant 
situation). It should be noted that the wavelength of UV light chosen for the photoinitiation 
(366 nm) did not photo-bleach the samples as the far-red (647 nm) ATTO dye was selected 
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for the cryogel functionalization. The ATTO functionalized cryogel cylinders were swollen in 
PBS and directly characterized. Figure 3D-F and Supporting Figure S3G-I reveal the 
macroporous structure of the cryogel samples in their hydrated state. It can be clearly seen 
that CSLM and SEM investigations show similar morphological characteristics. The 1 mm and 
2 mm sized cryogel cylinders show a very similar pore size distribution ranging between 
10 µm and 110 µm (Figure 3G) with average pore diameters of 40.5 µm and 48.3 µm 
respectively. By comparison, the 0.5 mm sized cryogel cylinders, have pore sizes that range 
between 1-60 µm (Figure 3G) and an average pore diameter of 16.4 µm (see Table S1 for 
general porosity characteristics of the cryogels). In summary, SEM and CLSM studies 
confirmed that the three different cryogel sizes consist of a continuous, highly macroporous 
structure. This high porosity should provide a high surface area to volume ratio (Table S1) for  
3.3 Raman and FTIR spectra analysis reveal a completely covalent network 
Raman and FTIR spectroscopy analysis were performed as complementary methods on the 
cylindrical PEGDA cryogels in comparison to the monomer and precursor solution. These two 
methods allow the confirmation of successful photoinitiated crosslinking of the PEGDA in the 
resulting cryogel scaffolds after UV irradiation (Figure S4 and Figure S5). Both spectral 
analyses confirmed the absence of characteristic vinyl C=C (1640 cm-1, Raman; 1620-1635 cm-
1, FTIR) and vinyl CH2 (1410 cm-1, Raman; 810 cm-1 and 1410 cm-1, FTIR) vibrations in the 
cryogel after the precursor solution was exposed to UV light for 3 minutes. In addition, the 
characteristic C=O vibration of the PEGDA ester groups (1723 cm-1, Raman; 1723 cm-1, FTIR) 
was reduced in intensity [31, 32] and shifted (1733 cm-1, Raman; 1730 cm-1, FTIR) after the 
crosslinking reaction was performed. These results provide the evidence of complete covalent 
bonding within the cryogel network and thus no free vinyl groups remain in the structure.  
3.4 The cryogel specific sponge-like morphology allows fast and reversible swelling  
The swelling properties of the three differently sized cylindrical PEGDA cryogels are shown in 
Figure S6. Due to their open sponge-like structure, which shows a high surface area to volume 
ratio (Table S1), water or other solvents can easily absorb into the cryogel cylinders through 
the interconnected pore structure of the scaffold. The swelling equilibrium of the different 
cryogels was reached within a few minutes, whereby an opaque appearance is obtained 
(related to the heterogeneous pore structure of the cryogels). The calculated volume swelling 
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degrees of the differently sized cryogels are, as expected, almost identical because they all 
consist of the same crosslinked material (PEGDA 700). In general, all three cylindrical cryogels 
can also simply be dried and stored under dry state conditions and re-swollen at any time as 
required. 
3.5 Cylindrical PEGDA cryogels can withstand high compressive stress 
The mechanical properties of the cryogels were analyzed by a compression test. The Figure 
S7 shows uniaxial compression stress-strain curves obtained for the cylindrical PEGDA 
cryogels, which has also been reported for other types of cryogel material [25, 28, 33]. The 
curve shape of the compression measurements follows an initial weak stress-strain response, 
which turns into a dramatic stress increase when higher strains are applied. The cylindrical 
PEGDA cryogels could withstand compression strain of 90% (up to about 160 kPa) without 
any cracks or destruction. Additionally, after a complete compression test, the cryogels could 
be easily regenerated to their original shape when immersed in PBS. In order to estimate the 
mechanical strength and elasticity of the cryogels, the average Young’s modulus (5 ± 0.5 kPa) 
was determined from the slope of the stress-strain curves (eq. (2)). Such rather low Young’s 
modulus demonstrates the elastic and spongy nature of these cryogel scaffolds, which 
provides them with appropriate physical property for applications in neuronal tissue 
engineering [34].  
3.6 Scaffolds loaded with LPC show minimal global release to the culture medium 
Figure 4A and 4B show a schematic representation of the proposed interactions between LPC 
and the cryogels, with a color change being noted due to the intense orange color of the 
fluorescently labelled LPC analogue used for this analysis (Figure 4C). There was no depletion 
of LPC concentration from the loading solution (Figure 4D), showing that loading to the 
cryogel scaffolds was simply by filling the swelled volume like a sponge with total amount of 
LPC loading being dependent on cryogel size (Figure 4E and Figure S8).  To determine the rate 
of LPC release to the medium below the culture insert, samples of the medium were analyzed 
for up to 16 hours of incubation. Figure 4F shows that different release profiles were obtained 
for differently sized cryogel cylinders. A plateau was reached for the 0.5 mm cryogels, but a 
greater amount of LPC was released from the larger cryogels with an almost linear release 
behavior from the 2 mm cryogels.   
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3.7 Cryogels induce focal demyelination of central nervous system slices  
LPC- or control medium-loaded cryogels were placed next to CNS slices for 16 hrs (as 
previously optimized [10]), using 2 mm diameter cryogels for cortical slices and 0.5 mm 
diameter cryogels for the smaller spinal cord slices (Figure 5A-D). These tissue areas were 
chosen to have either white matter (spinal cord) or grey matter (cortical) at the edge of the 
slice so that focal demyelination in both areas was possible from LPC diffusing in from the 
slice edge. These coronal brain slices or longitudinal spinal cord slices from new-born, wild 
type mice were allowed to myelinate in culture more than 2 weeks (Figure 5A-D), and  
immunofluorescence for myelin basic protein (MBP) was used as an indicator of the extent of 
myelination (Figure 5B,C).  
3.8 White matter demyelination 
0.5 mm LPC-loaded or saline loaded (control) cryogels were placed adjacent to longitudinal 
spinal cord sections, and the area close to the cryogel was compared to a distant area 
(unaffected) of the spinal cord (Figure 6, Figure S9A,B). Control cryogels induced no 
demyelination at either day 3 or day 14 (as expected) (Figure 6A). However, LPC loaded 
cryogels caused demyelination adjacent to the position of the cryogel which could be 
observed by a loss of MBP immunofluorescence staining at day 3 (Figure 6B), reaching 
approximately 0.5 mm into the slice (Figure 6C) or 26% of the spinal cord area. More myelin 
was lost within the lesion than at the perilesion area (Figure 6C). Neurofilament (NF) labelling 
(Figure 6B), showed that whilst demyelination had occurred, the axons had remained. As we 
would expect in response to demyelination, there is an invasion of the demyelinated area by 
IBA1+ microglia at this time-point as a mechanism to clear myelin debris (Figure 6B). This is 
absent from the slices treated with control cryogels (Figure 6A). From our work with global 
demyelination of CNS slices [10], and in vivo demyelination in the mouse [8], we would expect 
remyelination to occur by day 14. At this time-point, adjacent to the LPC-loaded cryogel 
position, myelin debris was absent and MBP+ myelin sheaths were visible again (Figure 6B) 
showing that remyelination had successfully occurred (quantified in Figure 6D). This 
demyelination and spontaneous remyelination occurred in a focal manner, with the distal 
region of the spinal cord not affected (Figure 6C,D, Figure S9B).  
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3.9 Grey matter demyelination 
To model grey matter demyelination in a focal manner, we tested the larger 2 mm cryogels 
placed adjacent to cultured coronal slices of mouse brain cortex, targeting the motor cortex 
(Figure 7A,B and Figure S9C,D).  Again, in contrast to slices treated with control cryogels, we 
saw focal areas of demyelination in the slices adjacent to the position of the cryogel, affecting 
the cortical layers I-V, reaching an extent of 0.4 mm (Figure 7B). The myelin debris took longer 
to clear in the cortical slices than spinal cord slices, reaching a nadir at the later time point of 
5 days (Figure 7B,C). At day 5, there was a focal lack of MBP+ immunofluorescence after 
application of the LPC-loaded cryogel, normal axonal staining with NF antibodies and invasion 
of the demyelinated area by IBA1+ microglia (Figure 7B). Perilesional areas had an 
intermediate amount of myelin, less than that on the contralateral side (Figure 7C). At day 
14, when we expect remyelination to have occurred, MBP+ myelin profiles returned, 
quantified in (Figure 7D) and the number of IBA1+ microglia reduced (Figure 7B). The 
contralateral hemisphere of the slice was not affected by the addition of the LPC-loaded 
cryogel (Figure S9D) showing that the action of the LPC was limited to the adjacent tissue area 
only (average lesion depth of 394 µm ±82 µm).   
 
In both cases of focal demyelination, in spinal cord and cortex, similarly to after global 
demyelination[10], we were able to successfully immunolabel for other markers of 
oligodendroglia, paranodal structures and proliferating cells, showing the potential use of this 
model to answer a variety of different biological questions (illustrated in Figures S10 and  
S11). 
 
4 Discussion 
LPC is widely used in the myelin field as a myelin toxin, and can be injected into the nervous 
system to produce precise and localized areas of demyelination [35]. Addition of LPC to CNS 
slice cultures offers a practical alternative to the use of whole organisms for studying the 
demyelination and remyelination processes that take place during MS progression. However, 
studies to date have shown that addition of LPC to culture medium below the slice, inevitably 
creates a uniform global demyelination effect [8, 10], thus not representing the uneven 
nature of the disease pathology. Direct injection into the slice is impractical due to the thin 
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depth of tissue required for this culture method. Furthermore, previous attempts only 
resulted global demyelination across the slice. 
In this research we sought a means of affecting only a small region of the tissue, leaving the 
rest in an unaltered, healthy condition. For this we proposed the use of macroporous cryogel 
scaffolds; their soft yet robust structure making them easy to handle and quick to soak up 
liquids like a sponge.  
A non-degradable, poly(ethylene glycol) based material was chosen for the relative inert 
nature it exhibits towards brain tissue [36]. Photo-initiated free radical polymerization of 
poly(ethylene glycol) diacrylate  was chosen for network formation due to the versatility that 
it allows in terms of defining the freezing schedule prior to, not during, the polymerization 
reaction. Unlike previous studies, where network formation (gelation) took place during the 
freezing process [33, 37-39], herein we could pre-determine the freezing parameters, then 
expose the monomer solution to ultraviolet light to initiate the reaction. Not only did this give 
good control over pore size (Figure 3), but it was a quick production method, with high 
reaction efficiency (all vinyl groups reacted Figure S4 and Figure S5). 
LPC loading to the cryogel scaffolds was achieved simply through filling the macropores and 
was therefore directly proportional to cryogel cylinder size (larger scaffolds were loaded with 
more LPC). Although hydrogen bond interactions between the hydroxide groups of the LPC 
and the various carbonyl functionalities of the network can take place, no depletion of the 
concentration of the loading solution was noticed (i.e. LPC is not being electrostatically drawn 
out of solution onto the scaffold). Since we hypothesized that cryogel scaffolds could be used 
to deliver LPC to CNS slices cultured on the air-liquid interface, we first wanted to analyze 
how the LPC would be released in such a set up. If too much LPC would be released to the 
medium instead of the neighboring tissue area, then no specific focal effect would be 
obtained, and global demyelination would result. It should be noted that in our study actually 
a very low total amount of LPC was effectively released from the PEG based cryogels, into the 
medium below the insert membrane (0.7 µg (0.5 mm cryogel), 5.1 μg (1 mm cryogel) and 12 
μg (2 mm cryogel) (Figure 4F) in comparison to the total loading amount of 5 – 100 μg (Figure 
S8). This is far below the level required to create the global demyelination model (0.5 
mg/mL)[10]. This was a very important finding, showing that the cryogel cylinders could 
potentially cause only focal demyelination in CNS slices rather than global demyelination of 
the whole tissue. In addition, due to the different loading and release profiles, we could 
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envisage that the different cryogel cylinder slices would be suitable for different tissue slice 
sizes (i.e. brain vs spinal cord). We therefore took advantage of these small cryogel cylinders 
to focally introduce LPC to different sized tissue slices (cortex and the spinal cord).  
For white matter lesions we used longitudinal spinal cord slices that were first left to 
myelinate ex vivo for more than 2 weeks. In the spinal cord, the white matter is located 
around the outermost area, and so should be amenable to demyelination from an adjacent 
LPC-loaded cryogel. In contrast to our previous global demyelination [8, 10], a focal region of 
demyelination was created in proximity to the cryogel placement (day 3) which, after removal 
of the cryogel, subsequently became remyelinated by day 14.  
Apart from the white matter pathology, there is now increasing evidence that in MS there is 
also demyelinating damage affecting grey matter areas where the neurons reside and that it 
correlates well with neurological disability [40, 41],[42-44]. We therefore wanted to see if LPC 
loaded cryogel scaffolds could be used to create specific grey matter lesions. If accomplished, 
this could allow researchers to analyze the effect of therapeutic strategies on both the white 
matter and grey matter individually. In that case the larger diameter cryogel scaffolds were 
used (2mm) for the larger cortical slices. Again, focal demyelination was achieved, this time 
after 5 days, and subsequent remyelination also occurred.  
To the best of our knowledge, these are the first such examples of non-uniform or “patchy” 
MS-like pathology in a central nervous system culture. These results not only prove the 
concept that focal demyelination can be set up using ex-vivo slice cultures, but also highlight 
the versatility of the approach as a means of focal tissue manipulation in general. Future 
studies will now focus on the underlying processes occurring during remyelination and the 
interplay between the healthy and pathological tissue regions, including microglia and 
oligodendrocyte recruitment. We envisage that this will not only give us a better 
understanding of the disease process, but provide a better disease-mimicking model to 
testing new therapeutic compounds.   
5 Conclusion 
We have induced focal demyelination of white matter and grey matter areas of mouse brain 
and spinal cord slice in vitro MS models using PEG-based cryogels loaded with LPC. Similarly 
to in global demyelination of CNS slices, we see demyelination and microglial invasion, 
followed by remyelination. However, the novelty of these models is that the focal pathology 
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surrounded by healthy tissue allows the study of recruitment of OPCs to these lesions, an 
important factor in at least 30% of MS lesions. Understanding grey matter pathology in MS is 
considered of increasing importance in neurodegeneration and cognitive dysfunction, and in 
cortical slices we have induced focal grey matter lesions. Slice cultures are an ideal tool for 
studying remyelination as they allow easy addition of drugs/cells/small molecules aiming to 
influence remyelination, with live imaging possible, enabling screening of compounds in vitro 
at moderate throughput before testing in vivo. We also predict that these soft but robust 
cryogel scaffolds may also be useful in applying LPC or other drugs (toxins or therapeutics) in 
vivo.  
This focal demyelinating ex vivo model represents a step forward in the tools available to 
improve understanding of CNS remyelination and to screen for pro-remyelination 
compounds, that may in the future be used in for therapies to help progressive MS. 
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Figure 1.  Schematic depiction of the preparation process of cylindrical PEGDA 
cryogels. 
(A) Synthesis of the PEGDA cryogel network via free radical photo-polymerization 
reaction within the liquid non-frozen microphase. (B) Empty polystyrene template sheets 
with cavities for the precursor solution. (C) Cryogel filled polystyrene sheets post 
polymerization. (D) Washed and dried cylindrical cryogels, removed from the 
polystyrene sheet cavities.   
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Figure 2.  Multi-pinhole confocal microscopy analysis of the polystyrene templates. 
(A) Photo images of empty and filled 2 mm diameter cryogel template. (B) 2D multi-
pinhole confocal microscopy analysis of the 2 mm diameter polystyrene template empty 
and filled post polymerization. (C) Profile analysis of the empty and filled 2 mm templates 
polystyrene sheets post polymerization. (D) 3D multi-pinhole confocal microscopy 
analysis of the 2 mm diameter polystyrene template empty and filled post 
polymerization.   
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Figure 3. Scanning electron microscopy and confocal laser fluorescence 
microscopy analysis of cylindrical PEGDA cryogel scaffolds. 
(A-C) Representative scanning electron microscopy images of a 2 mm cylindrical PEGDA 
cryogel scaffold in its dehydrated state shows its porous nature. (D-F) Confocal laser 
fluorescence microscopy analysis of ATTO 647 maleimide labelled cylindrical cryogel 
scaffolds with 0.5 mm (D), 1 mm (E), and 2 mm diameter (F) showing the high precision 
control over scaffold dimensions. (G) Pore size distribution of 0.5 mm, 1 mm and 2 mm 
diameter cryogels (swollen in PBS).   
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Figure 4. An illustration of the molecular interactions between the PEGDA cryogel 
network and the fluorescently labelled LPC (A): (1) Hydrogen bond interactions 
between the phosphonate group of LPC and the carbonyl functionality of PEGDA (2) 
Hydrogen bond interactions between the hydroxide group of LPC and the carbonyl 
 
 
26 
 
functionality of PEGDA. (B-C) PEGDA cryogel cylinders placed in the 6-well inserts in 
empty wells (top row) and wells containing media (bottom row). The cryogels turned 
into an orange colour after incubation in the fluorescently labelled LPC solution (top 
row). After 16 hours of release, the cryogels are discoloured (bottom row). (D-F) Loading 
and release properties of LPC from the 0.5-2 mm diameter PEGDA cryogels. (D) shows 
that the LPC concentration was completely unaffected by the cryogel loading process. (E) 
shows the loaded volume of the LPC solution to the different sized PEGDA cryogels after 
the soaking procedure. The loading volume capacity increases with the cryogel size. (F) 
shows a slow release profile with a low amount released from the cryogels over a period 
of 16 hours. (n = 4) (error bars represent the cumulative value of the standard error). 
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Figure 5: Technical information for slice cultures ex vivo 
(A) Diagram of angle of cutting of spinal cord and cortical hemispheres for cultures on 
membrane inserts in culture wells. (B and C) micrographs of cultured brain slice (B) and 
spinal cord slice (C) stained with an antibody against myelin basic protein (MBP) in green 
(scale bars represent 1mm). (D) Schematic representations of the placement of the 
cryogels adjacent to the tissue slices, showing their position on the insert relative to the 
tissue. 
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Figure 6: LPC loaded cryogels create a focal lesion in spinal cord ex-vivo slice 
cultures. 
(A) Schematic representation of a saline loaded cryogel (control condition) placed next 
to a spinal cord slice with corresponding timeline of study procedure. 
Immunohistochemistry of horizontal sections for MBP (green), NF (red), and IBA1 
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(white) for brain slices cultured in the control condition. Higher magnification images 
(zoomed) are taken from the regions marked by the dashed box, with IBA1 omitted for 
clarity. No demyelination occurs in this condition (scale bars represent 100 µm). (B) 
Schematic representation of a LPC loaded cryogel (test condition) placed next to a spinal 
cord slice with corresponding timeline. Micrographs taken at day 3 show extensive 
demyelination (lesion border shown by dashed line) with myelin debris marked with an 
asterisk in the zoomed images. As with the cortical sections, by day 14, the presence of 
increased numbers of myelinated axons is clear and IBA1+ microglial cells are more 
evenly distributed (not clustered around the lesion site), showing that spontaneous 
remyelination has occurred (scale bars represent 100 µm). (C) Quantification of the 
extent of demyelination at day 3. The region of the lesion shows a significant reduction in 
the area of MBP signalling compared to the saline control, the perilesion and distal to the 
lesion. Each point represents data from one animal. Data are shown as mean ±SEM. One-
way ANOVA with Tukey post-hoc test (*P<0.05, ** P<0.01, *** P<0.001). (D) 
Quantification of the extent of remyelination at day 14. The area of MBP+ signal was 
measured. The lesion area shows similar MBP signalling when compared to the saline 
control and the distal area. Each point represents data from one animal. Data are shown 
as mean ±SEM. One-way ANOVA with Tukey post-hoc test (P=0.0791 n.s.: non-
significant).   
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Figure 7: Focal lesion in cortical hemisphere cultures in ex vivo slice cultures 
created by LPC loaded cryogels 
(A) Schematic representation of a saline loaded cryogel (control condition) placed next 
to a cortical brain slice with corresponding timeline of study procedure. 
Immunohistochemistry of coronal sections for MBP (green), NF (red), and IBA1 (white) 
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for brain slices cultured in the control condition. Higher magnification images (zoomed) 
are taken from the regions marked by the dashed box, with IBA1 omitted for clarity. No 
demyelination occurs in this condition (scale bars represent 100 µm). (B) Schematic 
representation of a LPC loaded cryogel (test condition) placed next to a cortical brain slice 
with corresponding timeline. Micrographs taken at day 5 show extensive demyelination 
(lesion border shown by dashed line) with myelin debris marked with an asterisk in the 
zoomed images. By day 14 the presence of increased numbers of myelinated axons is 
clear and IBA1 microglial cells are more evenly distributed, showing that spontaneous 
remyelination has occurred (scale bars represent 100 µm). (C) Quantification of the 
extent of demyelination at day 5. The area of MBP+ signal was measured. The lesion area 
shows a significant reduction of MBP signalling compared to the saline control, the 
perilesion and contralateral hemisphere. Each point represents data from one animal. 
Data are shown as mean ±SEM. One-way ANOVA with Tukey post-hoc test (*P<0.05, 
**P<0.01, ***P<0.001,****P<0.0001). (D) Quantification of the extent of remyelination at 
day 14. The area of MBP+ signal was measured. The lesion area shows similar MBP 
signalling when compared to the saline control and the contralateral hemisphere. Each 
point represents data from one animal. Data are shown as mean ±SEM. One-way ANOVA 
with Tukey post-hoc test (P=0.7739 n.s.: non-significant).   
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Figure S1.  Multi-pinhole confocal microscopy analysis of the polystyrene 
templates. 
(A) Photo images of empty and filled 0.5 mm diameter cryogel template. (B) 2D multi-
pinhole confocal microscopy analysis of the 0.5 mm diameter polystyrene template 
empty and filled post polymerization. (C) Profile analysis of the empty and filled 0.5 mm 
templates polystyrene sheets post polymerization. (D) 3D multi-pinhole confocal 
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microscopy analysis of the 0.5 mm diameter polystyrene template empty and filled post 
polymerization.   
 
 
Figure S2.  Multi-pinhole confocal microscopy analysis of the polystyrene 
templates. 
(A) Photo images of empty and filled 1 mm diameter cryogel template. (B) 2D multi-
pinhole confocal microscopy analysis of the 1 mm diameter polystyrene template empty 
and filled post polymerization. (C) Profile analysis of the empty and filled 1 mm templates 
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polystyrene sheets post polymerization. (D) 3D multi-pinhole confocal microscopy 
analysis of the 1 mm diameter polystyrene template empty and filled post 
polymerization.   
 
 
Figure S3. Scanning electron microscopy analysis of cylindrical PEGDA cryogel 
scaffolds confocal laser fluorescence microscopy analysis. 
(A-F) Scanning electron microscopy images of cylindrical PEGDA cryogel scaffolds with 2 
mm (A,D), 1 mm (B,E) and 0.5 mm (C,F) diameter its dehydrated state showing the porous 
nature of the scaffold. (G-I) Confocal laser fluorescence microscopy analysis of ATTO 647 
maleimide labelled cylindrical cryogel scaffolds with 2 mm (G), 1 mm (H), and 0.5 mm 
diameter (F) showing the high precision control over scaffold dimensions.  
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Figure S4. FTIR analysis of the cryogels in comparison to the monomer.  
FTIR spectra of the non-crosslinked PEGDA monomer (blue) and the cylindrical shaped 
PEGDA cryogels (black), showing a complete reduction in the peak at 810 cm-1, 1620-
1635 cm-1  and 1410 cm-1 due to the radical photo-polymerization reaction of the acrylate. 
 
Figure S5. Raman spectra analysis of the cryogel scaffold. 
Raman spectra of the non-crosslinked PEGDA monomer (blue), the precursor solution 
with the non-crosslinked PEGDA monomer and HMPP as the photoinitiator (red) and the 
cylindrical shaped PEGDA sample after photo-crosslinking and cryo-polymerization 
(black), showing a complete reduction in the peak at 1410 cm-1 and 1640 cm-1 (blue/red 
to black) because of the radical photo-polymerization reaction of the acrylate. Due to the 
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use of the photoinitiator HMPP, the presence of aromatic C-H and C-C vibrations 
(1000 cm-1, 1600 cm-1 Raman; 750 cm-1 and 1647 cm-1, FTIR) with additionally related 
C=O vibrations (1680 cm-1, Raman) were evident in the cryogel spectrum. 
 
Figure S6.  Swelling properties of the cylindrical PEGDA cryogels. 
(A) Experimentally determined volume swelling properties of 0.5, 1 and 2 mm diameter 
size PEGDA cryogels in PBS at 37 °C. Data collected are presented as mean ± standard 
deviation (n=6). (B) Comparison of theoretical and experimentally determined diameter 
of the cylindrical PEGDA cryogels in PBS at 37 °C. Data collected are presented as mean ± 
standard deviation (n=6).  
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Figure S7.  Compression test of the cylindrical PEGDA cryogels. 
The black, red and blue curve represent an example of uniaxial compression stress-strain 
measurements obtained from the PEGDA cryogels (n = 10) at the rate of 1mm/min.  
 
Figure S8. Loaded amount of LPC from the 0.5-2 mm diameter PEGDA cryogels. A 
small amount, up to a max. of 0.11 mg was loaded to the cryogel scaffold from the loading 
stock solution containing 10 mg in total. 
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Figure S9. Tiled immunofluorescence pictures of large areas of focally 
demyelinated CNS tissue 
(A) Slide scanner image of a focal demyelinated lesion 3 days after treatment with LPC in 
spinal cord. (B) A representative micrograph image of the spinal cord distal to the 
placement of the LPC loaded cryogel after 3 days, showing no LPC induced demyelination. 
  (C) Tiled 20x images of a focal demyelinated lesion 5 days after treatment with LPC in a 
cortical slice. (D) A representative micrograph image of the cortex contralateral to the 
placement of the LPC loaded cryogel after 5 days, showing no LPC induced demyelination. 
In all pictures, immunofluorescence for MBP (green), axonal NF (red) and IBA1 (white) 
and scale bars represent 100 µm. 
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Figure S10. Examples of immunofluorescence in focally demyelinated spinal cord 
slice cultures 
Immunofluorescence of spinal cord slices not treated (control) and within the focal 
demyelinated lesion at 3 days after treatment with LPC, showing (A) MBP (green - 
myelin) and CC1 (red - mature oligodendrocytes) with a reduction in both after 
demyelination, and (B) MBP (green - myelin), OLIG2 (red - oligodendroglia) and Ki67 
(white – proliferating cells). Scale bars represent 100 µm. 
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Figure S11. Examples of immunofluorescence in focally demyelinated cortical 
slice cultures 
Immunofluorescence of coronal sections of cortical slices not treated (control), within 
the focal demyelinated lesion at 5 days after treatment with LPC, and after 
remyelination at 14 days after treatment with LPC showing (A) MBP (red - myelin) and 
OLIG2 (green - oligodendroglia) showing loss of both during demyelination and then 
recovery after remyelination, (B) MBP (red - myelin) and NG2 (green - OPCs) showing 
loss of both during demyelination followed by recovery after remyelination and (C) 
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MBP (magenta - myelin) NF (red - axons) and CASPR (green - paranode) showing 
normal clustering of CASPR protein on myelinated fibres in controls adjacent to the 
node of Ranvier (asterisks), but diffusion of CASPR along the axon (arrows) during 
demyelination, with the return of heminodal clustering upon remyelination. Scale bars 
represent 50 µm (A,B) and 10 µm(C).  
